Evaluation of clinical treatment of aspiration pneumonia in aged patients

VernacularTitle:52例老年吸入性肺炎治疗效果评价
Author: Guangjie LIU ; Yuxia ZHAO ; Jie XU ; Xiao CHEN
Publication Type:Journal Article
Keywords: Aspiration pneumonia; Ampicillin/sulbactam; Imipenem/cilastatin
From: Clinical Medicine of China 2009;25(7):716-718
CountryChina
Language:Chinese
Abstract: Objective To evaluate the efficacy of administration of ampicillin/sulbactam and imipenem/cilastatin in treatment of aspiration pneumonia in aged patients. Methods 26 aged patients was treated with aspira-tion pneumonia (2.25～3.00 g) through vessel injection twice perday,and another 26 patients was treated with imi-penem/cilastatin (0.5 g) through vessile injection every 6～8 hours. We evaluated the efficacy through assessing the temperature,the chest radiography,WBC and CRP,incidence of side effects,the time to cure and the clearance of bacteria. Results The cure rate was 84.6% (22/26) and 92.3% (24/26),respectively (χ2=0.19,P=0.66). The time to cure was 8.2±2.8 days and 7.5±1.6 days for the groups (t=1.107,P=0.274). Gastrointestinal side effects were observed in the group of ampicillin/sulbactarn;slight abnormality of liver function occurred in the group of imipenem/cilastatin ;all above adverse effects in two groups were rapidly and completely disappeared after therapy stopped. Conclusion Both ampicillin/sulbactam and imipenem/cilastatin are effective antibiotics to treat aspiration pneumonia in aged patients.